These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12933923)

  • 1. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment.
    Craig J; Young CA; Ennis M; Baker G; Boggild M
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1225-30. PubMed ID: 12933923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
    Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
    Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
    Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.
    Fierro B; Salemi G; Brighina F; Buffa D; Conte S; La Bua V; Piazza A; Savettieri G
    Acta Neurol Scand; 2002 Mar; 105(3):152-7. PubMed ID: 11886356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
    Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
    Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis.
    Patzold T; Schwengelbeck M; Ossege LM; Malin JP; Sindern E
    Acta Neurol Scand; 2002 Mar; 105(3):164-8. PubMed ID: 11886358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation.
    Elovaara I; Kuusisto H; Paalavuo R; Särkijärvi S; Lehtimäki T; Huhtala H; Vilpo J
    Acta Neurol Scand; 2006 Mar; 113(3):163-6. PubMed ID: 16441245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
    Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
    Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
    Frequin ST; Lamers KJ; Barkhof F; Borm GF; Hommes OR
    Acta Neurol Scand; 1994 Aug; 90(2):105-10. PubMed ID: 7801735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006921. PubMed ID: 19588409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
    Ramo-Tello C; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Grau-López L
    Mult Scler; 2016 Jan; 22(1):117-21. PubMed ID: 26540732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses.
    Filipović Grčić P; Matijaca M; Lušić I; Čapkun V
    Med Sci Monit; 2011 Dec; 17(12):CR704-10. PubMed ID: 22129902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response.
    Evangelopoulos ME; Nasiri-Ansari N; Kassi E; Papadopoulou A; Evangelopoulos DS; Moutsatsou P
    Sci Rep; 2021 Sep; 11(1):19462. PubMed ID: 34593869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
    Rossier P; Wade DT
    Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effectiveness study comparing acupuncture, physiotherapy, and their combination in poststroke rehabilitation: a multicentered, randomized, controlled clinical trial.
    Zhuangl LX; Xu SF; D'Adamo CR; Jia C; He J; Han DX; Lao LX
    Altern Ther Health Med; 2012; 18(3):8-14. PubMed ID: 22875557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-examining the effects of high-dose intravenous methylprednisolone for secondary progressive multiple sclerosis.
    Jalipa FGU; Espiritu AI; Pasco PMD
    Neurodegener Dis Manag; 2021 Apr; 11(2):177-185. PubMed ID: 33703936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.